Acta Crystallographica Section F Structural Biology and Crystallization Communications · 2009 · 152 citations · 20 references
Life SciencesMedicinal ChemistryPharmacologyDrug DesignEnzymologyStructural BiologyActive Site ArchitectureEnzyme InhibitionLigand BindingProtein StructureProtein-ligand BindingStructure-activity Relationship AnalysisActive Site AnalysisActive Site CharacterizationActive Site ResiduesCarbonic Anhydrase InhibitorsCrystal Structure RefinementEnzyme Inhibitor DiscoveryResidue-directed Inhibitor Design
The crystal structure of human carbonic anhydrase II (CA II) complexed with the inhibitor acetazolamide (AZM) has been determined at 1.1 A resolution and refined to an R(cryst) of 11.2% and an R(free) of 14.7%. As observed in previous CA II-inhibitor complexes, AZM binds directly to the zinc and makes several key interactions with active-site residues. The high-resolution data also showed a glycerol molecule adjacent to the AZM in the active site and two additional AZMs that are adventitiously bound on the surface of the enzyme. The co-binding of AZM and glycerol in the active site demonstrate that given an appropriate ring orientation and substituents, an isozyme-specific CA inhibitor may be developed.
20
A short history of<i>SHELX</i>
George M. Sheldrick · Acta Crystallographica Section A Foundations of Crystallography · 2007 · 87.4K citations · Full text
The PyMOL Molecular Graphics System
Warren L. DeLano · Medical Entomology and Zoology · 2002 · 18.1K citations